Ben Hatano

Ben Hatano is a seasoned professional in clinical science and medical research, currently serving as the Head of Clinical Science at Genmab since April 2024. Previously, Ben held various notable positions at Bristol Myers Squibb from July 2021 to April 2024, including TA-Head Oncology Clinical Development and Senior Clinical Trial Physician. Prior experiences include roles at Celgene as Clinical Research Physician and Director, Novartis as Senior Clinical Lead, and AstraZeneca as Medical Director for R&D. Ben began a career in military medicine with significant leadership positions in the JGSDF, including Chief of Test & Evaluation Section and Medical Liaison Officer. With a robust educational background that includes an MBA from Kenichi Ohmae Graduate School of Business and a PhD in Clinical Pathology from Fukuoka University, Ben combines advanced scientific expertise with strategic business acumen in the healthcare field.